Prospective Observational Post-marketing Study of Tafluprost 0.0015%/Timolol 0.5% Combination Ophthalmic Solution for Glaucoma and Ocular Hypertension: Short-Term Efficacy and Safety
Crossref DOI link: https://doi.org/10.1007/s40123-016-0057-3
Published Online: 2016-08-04
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Takagi, Yasutaka
Osaki, Hirotaka
Yamashita, Tomohiro
Kai, Yasuhiko